Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Adam Gridley currently holds 7,000 shares of HISTOGENICS CORP (HSGX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Adam Gridley has been a net seller of HSGX stock. They have purchased $14.3K and sold $96.0K worth of shares.
Adam Gridley's most recent insider trade was on May 16, 2018, when they purchased 2,000 shares at $2.15 per share.
Adam Gridley serves as Executive at HISTOGENICS CORP (HSGX). They have executed 13 insider transactions totaling $110.3K over their tenure at the company.
Adam Gridley holds the position of Executive at HISTOGENICS CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 17 years and currently hold a stake valued at $0.
Adam Gridley has shown a selling trading pattern, with $14.3K in total purchases and $96.0K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Adam Gridley was on Feb 16, 2010, when they sold $117.5K worth of BFRM shares. This transaction involved 21,562 shares at $5.45 per share.
Adam Gridley currently owns 7,000 shares of HISTOGENICS CORP (HSGX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Adam Gridley's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Adam Gridley has 13 Form 4 filings on record as an insider at HISTOGENICS CORP.
Set alerts for Adam Gridley and 40,000+ other insiders.